Market Trends Johnson and Johnson will not exercise worldwide license option for HexaBody-CD38, says Genmab (GMAB:NASDAQ)By admin8996erT0allMarch 10, 2025 Genmab A/S (Nasdaq: GMAB) said on Monday that Johnson & Johnson (J&J) has decided not to exercise its option to…
